Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
Resource Type
Article
Authors
Ascierto, Paolo A ; Del Vecchio, Michele ; Robert, Caroline ; Mackiewicz, Andrzej ; Chiarion-Sileni, Vanna ; Arance, Ana ; Lebbé, Céleste ; Bastholt, Lars ; Hamid, Omid ; Rutkowski, Piotr ; McNeil, Catriona ; Garbe, Claus ; Loquai, Carmen ; Dreno, Brigitte ; Thomas, Luc ; Grob, Jean-Jacques ; Liszkay, Gabriella ; Nyakas, Marta ; Gutzmer, Ralf ; Pikiel, Joanna ; Grange, Florent ; Hoeller, Christoph ; Ferraresi, Virginia ; Smylie, Michael ; Schadendorf, Dirk ; Mortier, Laurent ; Svane, Inge Marie ; Hennicken, Delphine ; Qureshi, Anila ; Maio, Michele
Source
In The Lancet Oncology May 2017 18(5):611-622
Subject
Primary Research Articles
Language
ISSN
1470-2045